Local delivery of a low molecular weight heparin following stent implantation in the pig coronary artery

Basic Research in Cardiology

Volumn 95, Issue 3, 2000, Pages 173-178

  Baumbach, Andreas ^a   Oberhoff, Martin ^a   Herdeg, Christian ^a   Lerch, Matthias ^a   Schröder, Stephen ^a   Meisner, Christoph ^b   Rübsamen, Klaus ^b   Karsch, Karl R ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

Local drug delivery; Low molecular weight heparin; Restenosis; Stent

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY CATHETERIZATION; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY STENT; DISLOCATION; DRUG DELIVERY SYSTEM; HISTOPATHOLOGY; IMPLANTATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; RESTENOSIS; SWINE; TREATMENT FAILURE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTICOAGULANTS; ARTERIES; BALLOON DILATATION; CORONARY DISEASE; CORONARY VESSELS; HEPARIN, LOW-MOLECULAR-WEIGHT; INJECTIONS, INTRA-ARTERIAL; STENTS; SWINE; TREATMENT FAILURE; TUNICA MEDIA;

EID: 0034035346     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003950050179     Document Type: Article

References (26)

1. Axel DI, Kunert W, Göggelmann Ch, Oberhoff M, Herdeg C, Küttner A, Wild DH, Brehm BR, Riessen R, Kövecker G, Karsch KR (1997) Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 96: 636-645
2. Bartorelli AL, DeCesare NB, Kaplan AV, Fabbiocchi F, Montorsi P, Squadroni L, Galli S, Sganzeria P, Loaldi A (1997) Local heparin delivery prior to coronary stent implantation: acute and six-month clinical and angiographic results. Cathet Cardiovasc Diagn 42: 313-320
3. Baumbach A, Herdeg C, Kluge M, Oberhoff M, Lerch M, Haase KK, Wolter C, Schröder S, Karsch KR (1999) Local drug delivery: impact of pressure, substance characteristics and stenting on drug transfer into the arterial wall. Cathet Cardiovasc Intervent 47: 102-106
4. Camenzind E, Kint PP, Di Mario C, Lighart J, Van der Giessen WJ, Boersma E, Serruys PW (1995) Intracoronary heparin delivery in humans. Acute feasibility and long-term results. Circulation 92: 2463-2472
5. Faxon DP, Spiro TE, Minor S, Coté G, Douglas J, Gottlieb R, Califf RM, Dorosti K, Topol EJ, Gordon JB, Ohmen M, and the ERA Investigators (1994) Low molecular weight heparin in prevention of restenosis after angioplasty. Results of Enoxaparin Restenosis (ERA) Trial. Circulation 90: 908-914
6. Gonschior P, Goetz AE, Huehns TY, Höfling B (1995) A new catheter for prolonged drug application. Coronary Artery Dis 6: 329-334
7. Gottsauner-Wolf M, Jang Y, Penn MS, Kaplan AV, Ellis SG, Chisolm GM, Topol EJ, Lincoff AM (1997) Quantitative evaluation of local drug delivery using the InfusaSleeve catheter. Cathet Cardiovasc Diagn 42: 102-108
8. Hamm CW, Reimers J, Ischinger T, Rupprecht H-J, Berger J, Bleifeld W (1994) A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 331: 1037-1043
9. Hanke H, Kamenz J, Hassenstein S, Oberhoff M, Haase KK, Baumbach A, Betz E, Karsch KR (1995) Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting. Eur Heart J 16: 785-793
10. Herdeg C, Blattner A, Oberhoff M, Baumbach A, Küttner A, Horch B, Kunert W, Haase KK, Karsch KR (1997) Local delivery of paclitaxel in the rabbit carotid artery results in reduced neointima formation and vessel enlargement. Eur Heart J 18: 416-416 (Abstract)
11. Herdeg C, Oberhoff M, Baumbach A, Haase KK, Horch B, Kranzhöfer A, Karsch KR (1997) Local drug delivery with the porous balloon in the rabbit: assessment of vascular injury for an improvement of application parameters. Cathet Cardiovasc Diagn 41: 308-314
12. Hoffmann R, Mintz, GS, Dussaillant GR, Popma JJ, Pichard A, Satler LF, Kent KM, Griffin J, Leon MB (1996) Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 94: 1247-1254
13. Huckle WR, Drag MD, Acker WR, Powers M, McFall RC, Holder DJ, Fujita T, Stabilito II, Kim D, Ondeyka D, Mantlo NB, Chang RSL, Reilly CF, Schwartz RS, Greenlee WJ, Johnson RG Jr (1996) Effects of subtype-selective and balanced angiotensin II receptor antagonists in a porcine coronary artery model of vascular restenosis. Circulation 93: 1009-1019
14. Kaplan AV, Vandormael MG, Hofmann M, Weil HJ, Stoerger H, Krajcar M, Gallant P, Simpson JB, Reifart N (1996) Heparin delivery at the site of angioplasty with a novel drug delivery sleeve. Am J Cardiol 77: 307-310
15. Kent KM, Bentivoglio LG, Block PC, Bourassa MG, Cowley MJ, Dorros G, Detre KM, Gosselin AJ, Grüntzig AR, Kelsey SF, Mock MB, Mullin SM, Passamani ER, Myler RK, Simpson J, Stertzer SH, Van Raden MJ, Williams DO (1984) Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung, and Blood Institute PTCA Registry. Am J Cardiol 53: 27C-31C
16. Meyer BJ, Fernandez-Ortis A, Mailhac A, Falk E, Badimon L, Michael AD, Chesebro JH, Fuster V, Badimon JJ (1994) Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty. Circulation 90: 2474-2480
17. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong C, Hong MK, Kovach JA, Leon MB (1996) Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation 94: 35-43
18. Moura A, Lam JY, Hebert D, Kermode JR, Grant GW, Robitaille D, Klein EJ, Yock PG, Simpson JB, Kaplan AV (1995) Intramural delivery of agent via a novel drug-delivery sleeve. Histological and functional evaluation. Circulation 92: 2299-2305
19. Muller DWM, Ellis SG, Topol EJ (1992) Experimental models of coronary artery restenosis. J Am Coll Cardiol 19:418-432
20. Oberhoff M, Baumbach A, Herrmann T, Diehl C, Maier R, Athanasiadis A, Herdeg C, Bohnet A, Haase KK, Voelker W, Baildon R, Veldhof S, Karsch KR (1998) Local and systemic delivery of low molecular weight heparin following PTCA: acute results and 6-month follow-up of the initial clinical experience with the porous balloon (PILOT-Study). Cathet Cardiovasc Diagn 44: 267-274
21. Oberhoff M, Herdeg C, Baumbach A, Shamet K, Kranzhöfer A, Weingärtner O, Rübsamen K, Kluge M, Karsch KR (1997) Time course of smooth muscle cell proliferation after local drug delivery of low molecular weight heparin using a porous balloon catheter. Cathet Cardiovasc Diagn 41: 268-274
22. Schwartz RS, Edwards WD, Bailey KR, Camrud AR, Jorgenson MA, Holmes DRJ (1994) Differential neointimal response to coronary artery injury in pigs and dogs. Implications for restenosis models. Arterioscler Thromb 14: 395-400
23. Schwartz RS, Holder DJ, Holmes DRJ, Veinot JP, Camrud AR, Jorgenson MA, Johnson RG (1996) Neointimal thickening after severe coronary artery injury is limited by short-term administration of a factor Xa inhibitor. Results in a porcine model. Circulation 93: 1542-1548
24. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR (1990) Restenosis after balloon angioplasty. A practical proliferative model in porcine coronary arteries. Circulation 82: 2190-2200
25. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L (1987) Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 317: 701-706
26. Wolinsky H, Lin C-S (1991) Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty. J Am Coll Cardiol 17: 174B-178B